Related Experiment Video
Updated: Dec 3, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19
Jesus Alvarez-Garcia1, Samuel Lee2, Arjun Gupta2
1The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Cardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/j_alvarezgarcia.
Insights
Patients with heart failure (HF) hospitalized with COVID-19 faced worse outcomes, including higher risks of mechanical ventilation and mortality. These increased risks persisted regardless of left ventricular ejection fraction (LVEF).
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Patients with pre-existing heart failure (HF) represent a vulnerable population during the coronavirus disease-2019 (COVID-19) pandemic.
- Limited data exist on the specific risks and outcomes for HF patients hospitalized with COVID-19.
Purpose of the Study:
- To describe the clinical characteristics and outcomes of patients with HF admitted to the hospital for COVID-19.
- To identify factors associated with adverse outcomes in this patient cohort.
Main Methods:
- A retrospective analysis of 6,439 patients hospitalized with COVID-19 was conducted.
- Electronic health records were used to capture clinical data and outcomes, including length of stay, ICU admission, mechanical ventilation, and mortality.
- Manual chart abstraction was performed for patients with a history of HF to determine etiology, functional class, and left ventricular ejection fraction (LVEF).
Main Results:
- Patients with a history of HF experienced significantly longer hospital stays (8 vs. 6 days) compared to those without HF.
- HF patients had a substantially higher risk of requiring mechanical ventilation (22.8% vs. 11.9%) and in-hospital mortality (40.0% vs. 24.9%).
- These adverse outcomes were consistent across different levels of LVEF.
Conclusions:
- A history of heart failure is an independent risk factor for severe outcomes, including mechanical ventilation and mortality, in patients hospitalized with COVID-19.
- The findings highlight the critical need for close monitoring and tailored management strategies for HF patients during COVID-19 outbreaks.
Background:
Patients with pre-existing heart failure (HF) are likely at higher risk for adverse outcomes in coronavirus disease-2019 (COVID-19), but data on this population are sparse.
Objectives:
This study described the clinical profile and associated outcomes among patients with HF hospitalized with COVID-19.
Methods:
This study conducted a retrospective analysis of 6,439 patients admitted for COVID-19 at 1 of 5 Mount Sinai Health System hospitals in New York City between February 27 and June 26, 2020. Clinical characteristics and outcomes (length of stay, need for intensive care unit, mechanical ventilation, and in-hospital mortality) were captured from electronic health records. For patients identified as having a history of HF by International Classification of Diseases-9th and/or 10th Revisions codes, manual chart abstraction informed etiology, functional class, and left ventricular ejection fraction (LVEF).
Results:
Mean age was 63.5 years, and 45% were women. Compared with patients without HF, those with previous HF experienced longer length of stay (8 days vs. 6 days; p < 0.001), increased risk of mechanical ventilation (22.8% vs. 11.9%; adjusted odds ratio: 3.64; 95% confidence interval: 2.56 to 5.16; p < 0.001), and mortality (40.0% vs. 24.9%; adjusted odds ratio: 1.88; 95% confidence interval: 1.27 to 2.78; p = 0.002). Outcomes among patients with HF were similar, regardless of LVEF or renin-angiotensin-aldosterone inhibitor use.
Conclusions:
History of HF was associated with higher risk of mechanical ventilation and mortality among patients hospitalized for COVID-19, regardless of LVEF.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure
Heart Failure I: Introduction